Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR0LR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,405
Award facts
- Contract value 100% obligated
- $26,405.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,405.27 delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Stelara 45 mg/0.5 mL syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 15, 2026. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the vehicle for comprehensive pharmaceutical supply to military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply a wide range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This particular delivery order for Stelara, an immunosuppressive medication used in treating inflammatory conditions, reflects the company's continued role in supporting the Defense Health Agency and broader military healthcare requirements through the DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FR0LR?
SPE2DR26FR0LR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FR0LR worth?
The government has obligated $26,405 on SPE2DR26FR0LR.
Is contract SPE2DR26FR0LR an order under another contract?
Yes. SPE2DR26FR0LR is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0LR competed?
The extent of competition for SPE2DR26FR0LR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award